ICU Medical Inc.

NAS: ICUI

GO
/marketstate/country/us

Market open

 --Real time quotes

May 19, 2022, 10:43 a.m.

/zigman2/quotes/208026181/composite

$

179.76

Change

+0.51 +0.28%

Volume

Volume 17,750

Real time quotes

/zigman2/quotes/208026181/composite

Previous close

$ 179.25

$ 179.76

Change

+0.51 +0.28%

Day low

Day high

$176.76

$180.44

Open

52 week low

52 week high

$167.47

$282.00

Open

Insider Actions for ICU Medical Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/12/2022 George A. Lopez
Director
17   Acquisition at $174.66 per share. 2,969
05/12/2022 George A. Lopez
Director
9,329   Acquisition at $174.17 per share. 1,624,831
05/12/2022 George A. Lopez
Director
7,092   Acquisition at $173.07 per share. 1,227,412
05/12/2022 George A. Lopez
Director
4,917   Acquisition at $172.24 per share. 846,904
05/12/2022 George A. Lopez
Director
4,480   Acquisition at $170.79 per share. 765,139
05/12/2022 Virginia Sanzone
VP, General Counsel
750   Disposition at $173.56 per share. 130,170
05/12/2022 Elisha Wade Finney
Director
217   Disposition at $170.53 per share. 37,005
05/11/2022 David C. Greenberg
Director
433   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2022 Elisha Wade Finney
Director
433   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2022 David F. Hoffmeister
Director
433   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2022 Donald M. Abbey
Director
433   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2022 Laurie Hernandez
Director
352   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2022 Kolleen T. Kennedy
Director
129   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Vivek Jain
Chairman and CEO; Director
1,328   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Christian B. Voigtlander
Chief Operating Officer
1,163   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Daniel Woolson
VP, GM-Infusion Capital
894   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Brian M. Bonnell
Chief Financial Officer
1,163   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Kevin J. McGrody
Chief Accounting Officer
442   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Virginia Sanzone
VP, General Counsel
1,196   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Vivek Jain
Chairman and CEO; Director
2,524   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Christian B. Voigtlander
Chief Operating Officer
2,209   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Daniel Woolson
VP, GM-Infusion Capital
2,020   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Brian M. Bonnell
Chief Financial Officer
2,209   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Kevin J. McGrody
Chief Accounting Officer
841   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2022 Virginia Sanzone
VP, General Counsel
2,272   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Vivek Jain
Chairman and CEO; Director
760   Derivative/Non-derivative trans. at $242.93 per share. 184,626
03/06/2022 Vivek Jain
Chairman and CEO; Director
932   Derivative/Non-derivative trans. at $242.93 per share. 226,410
03/06/2022 Christian B. Voigtlander
Chief Operating Officer
816   Derivative/Non-derivative trans. at $242.93 per share. 198,230
03/06/2022 Christian B. Voigtlander
Chief Operating Officer
760   Derivative/Non-derivative trans. at $242.93 per share. 184,626
03/06/2022 Daniel Woolson
VP, GM-Infusion Capital
628   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Daniel Woolson
VP, GM-Infusion Capital
639   Derivative/Non-derivative trans. at $242.93 per share. 155,232
03/06/2022 Brian M. Bonnell
Chief Financial Officer
816   Derivative/Non-derivative trans. at $242.93 per share. 198,230
03/06/2022 Brian M. Bonnell
Chief Financial Officer
380   Derivative/Non-derivative trans. at $242.93 per share. 92,313
03/06/2022 Kevin J. McGrody
Chief Accounting Officer
466   Derivative/Non-derivative trans. at $242.93 per share. 113,205
03/06/2022 Kevin J. McGrody
Chief Accounting Officer
532   Derivative/Non-derivative trans. at $242.93 per share. 129,238
03/06/2022 Virginia Sanzone
VP, General Counsel
839   Derivative/Non-derivative trans. at $242.93 per share. 203,818
03/06/2022 Virginia Sanzone
VP, General Counsel
760   Derivative/Non-derivative trans. at $242.93 per share. 184,626
03/06/2022 Vivek Jain
Chairman and CEO; Director
1,444   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Vivek Jain
Chairman and CEO; Director
1,772   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Christian B. Voigtlander
Chief Operating Officer
1,551   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Christian B. Voigtlander
Chief Operating Officer
1,444   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Daniel Woolson
VP, GM-Infusion Capital
1,418   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Daniel Woolson
VP, GM-Infusion Capital
1,444   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Brian M. Bonnell
Chief Financial Officer
1,551   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Brian M. Bonnell
Chief Financial Officer
722   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Kevin J. McGrody
Chief Accounting Officer
886   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Kevin J. McGrody
Chief Accounting Officer
1,011   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Virginia Sanzone
VP, General Counsel
1,595   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2022 Virginia Sanzone
VP, General Counsel
1,444   Derivative/Non-derivative trans. at $0 per share. 0
03/03/2022 Vivek Jain
Chairman and CEO; Director
36,000   Disposition at $240 per share. 8,640,000
03/03/2022 Vivek Jain
Chairman and CEO; Director
36,000   Derivative/Non-derivative trans. at $58.79 per share. 2,116,440
12/30/2021 Vivek Jain
Chairman and CEO; Director
1,159   Disposition at $240 per share. 278,160
12/30/2021 Vivek Jain
Chairman and CEO; Director
1,159   Derivative/Non-derivative trans. at $58.79 per share. 68,137
12/29/2021 Vivek Jain
Chairman and CEO; Director
10,677   Disposition at $240 per share. 2,562,480
12/29/2021 Vivek Jain
Chairman and CEO; Director
10,677   Derivative/Non-derivative trans. at $58.79 per share. 627,700
12/28/2021 Vivek Jain
Chairman and CEO; Director
164   Disposition at $240 per share. 39,360
12/28/2021 Vivek Jain
Chairman and CEO; Director
164   Derivative/Non-derivative trans. at $58.79 per share. 9,641
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Disposition at $240 per share. 2,880,000
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Disposition at $240 per share. 2,880,000
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Derivative/Non-derivative trans. at $58.79 per share. 705,480
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Derivative/Non-derivative trans. at $58.79 per share. 705,480
09/15/2021 Robert S. Swinney
Director
2,157   Disposition at $243 per share. 524,151

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
30 Purchases
21 Sales
92,405
51,481
Last 6 months
33 Purchases
24 Sales
104,405
63,481
Last 12 months
39 Purchases
38 Sales
149,124
97,427

Officers and Executives

Mr. Vivek Jain
Chairman & Chief Executive Officer
Mr. Christian Voigtlander
Chief Operating Officer
Mr. Brian M. Bonnell
Chief Financial Officer & Treasurer
Mr. Krishna Uppugonduri
VP-Quality, Medical & Regulatory Affairs
Mr. Daniel Woolson
Vice President & General Manager-Infusion Systems
Dr. George A. Lopez
Director
Mr. Thomas D. McCall
VP-Marketing & Communications, GM-Critical Care
Mr. Clay Fradd
Vice President-Human Resources
Ms. Virginia Sanzone
Secretary, Vice President & General Counsel
Ms. Laurie Hernandez
Independent Director
Ms. Kolleen T. Kennedy
Independent Director
Mr. William C. Seeger
Independent Director
Mr. David C. Greenberg
Lead Independent Director
Ms. Elisha Wade Finney
Independent Director
Mr. Donald M. Abbey
Independent Director
Mr. David F. Hoffmeister
Independent Director
Link to MarketWatch's Slice.